These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16185581)

  • 21. [Albumin dialysis MARS (Molecular Adsorbent Recirculating System) as a bridge for liver transplantation in acute liver failure. Report of three cases].
    Contreras J; Poniachik J; Oksenberg D; Cortés C; Valera JM; Cotera A; Pacheco A; Segovia E; Sanhueza ME; Boltansky A; Rojas J; Guerrero J; Díaz JC
    Rev Med Chil; 2004 May; 132(5):601-7. PubMed ID: 15279147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
    Mitzner SR
    Ann Hepatol; 2011 May; 10 Suppl 1():S21-8. PubMed ID: 21566251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological data.
    Mitzner S; Loock J; Peszynski P; Klammt S; Majcher-Peszynska J; Gramowski A; Stange J; Schmidt R
    Metab Brain Dis; 2002 Dec; 17(4):463-75. PubMed ID: 12602522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albumin regeneration in liver support-comparison of different methods.
    Mitzner S; Klammt S; Stange J; Schmidt R
    Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure.
    Sen S; Jalan R
    Perfusion; 2004; 19 Suppl 1():S43-8. PubMed ID: 15161063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.
    Vaid A; Chweich H; Balk EM; Jaber BL
    ASAIO J; 2012; 58(1):51-9. PubMed ID: 22210651
    [TBL] [Abstract][Full Text] [Related]  

  • 27.  Early initiation of MARS® dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation.
    Pillukat MH; Schomacher T; Baier P; Gabriëls G; Pavenstädt H; Schmidt HH
    Ann Hepatol; 2016; 15(5):775-87. PubMed ID: 27493118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver support systems: will they ever reach prime time?
    Bañares R; Catalina MV; Vaquero J
    Curr Gastroenterol Rep; 2013 Mar; 15(3):312. PubMed ID: 23392862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extracorporeal liver support of liver failure].
    Gerth HU; Pohlen M; Pavenstädt H; Schmidt H
    Z Gastroenterol; 2017 Apr; 55(4):383-393. PubMed ID: 28293919
    [TBL] [Abstract][Full Text] [Related]  

  • 30.  Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis.
    Díaz FC; Sáez-González E; Benlloch S; Álvarez-Sotomayor D; Conde I; Polo B; García M; Rodríguez M; Prieto M
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):939-943. PubMed ID: 27740530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
    Chiu A; Chan LM; Fan ST
    Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system.
    Sen S; Jalan R; Williams R
    Int J Biochem Cell Biol; 2003 Sep; 35(9):1306-11. PubMed ID: 12798344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin Dialysis for Liver Failure: A Systematic Review.
    Tsipotis E; Shuja A; Jaber BL
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):382-90. PubMed ID: 26311600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland.
    Kantola T; Ilmakunnas M; Koivusalo AM; Isoniemi H
    Scand J Surg; 2011; 100(1):8-13. PubMed ID: 21482500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albumin dialysis MARS: knowledge from 10 years of clinical investigation.
    Mitzner SR; Stange J; Klammt S; Koball S; Hickstein H; Reisinger EC
    ASAIO J; 2009; 55(5):498-502. PubMed ID: 19730006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure.
    Saliba F
    Crit Care; 2006 Feb; 10(1):118. PubMed ID: 16542471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [MARS in fulminant liver failure. The Chilean experience].
    Poniachik Teller J; Contreras Basulto J
    Gastroenterol Hepatol; 2005 Feb; 28(2):95-9. PubMed ID: 15710090
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging indications for albumin dialysis.
    Sen S; Williams R; Jalan R
    Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child.
    Hommann M; Kasakow LB; Geoghegan J; Kornberg A; Schotte U; Fuchs D; Hermann J; Zintl F; Scheele J
    Pediatr Transplant; 2002 Aug; 6(4):340-3. PubMed ID: 12234277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How can liver toxins be removed? Filtration and adsorption with the Prometheus system.
    Vienken J; Christmann H
    Ther Apher Dial; 2006 Apr; 10(2):125-31. PubMed ID: 16684213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.